Candesartan cilexetil/hydrochlorothiazide combination treatment versus high-dose candesartan cilexetil monotherapy in patients with mild to moderate cardiovascular risk (CHILI Triple T)

BACKGROUND: Candesartan cilexetil has been shown to effectively reduce blood pressure and cardiovascular risk. Whether it is advantageous to combine candesartan cilexetil with low-dose hydrochlorothiazide (HCTZ) or uptitrate it in cases of insufficient blood pressure control has not been fully inves...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Bönner, Gerd, Landers, Bernhard, Bramlage, Peter
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Dove Medical Press 2011
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3049544/
https://ncbi.nlm.nih.gov/pubmed/21415922
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S17004
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia